Homozygous familial hypercholesterolaemia: New hope for getting patients to goal?

Management of homozygous familial hypercholesterolaemia is challenging. What are the prospects for attaining LDL cholesterol goal with novel therapies? This latest commentary discusses the new findings for evinacumab, an ANGPTL3 monoclonal antibody.

Source: Atherosclerosis - May 24, 2020 Category: Cardiology Authors: Jane Stock Tags: EAS Updates Source Type: research